Beetham Thomas W. 4
4 · Kiniksa Pharmaceuticals, Ltd. · Filed Mar 23, 2021
Insider Transaction Report
Form 4
Beetham Thomas W.
Chief Legal Officer10% Owner
Transactions
- Award
Restricted Share Units
2021-03-20+5,855→ 5,855 total→ Class A Common Shares (5,855 underlying) - Award
Restricted Share Units
2021-03-20+4,287→ 4,287 total→ Class A Common Shares (4,287 underlying)
Footnotes (3)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
- [F2]The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2022, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.
- [F3]The performance criteria for these RSUs were met. The RSUs will vest in a single installment on March 20, 2023, subject to the Reporting Person's continuous employment with the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSUs.